China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug
Links shared publicly online about this topic.
- 1,435total visits
China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug
China Pharma Holdings, Inc. (China Pharma) (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, announced that the Company has completed clini
View full resource at medicalnewstoday.com
Tags: High Blood Pressure Medication, Drug, Pharma, Clinical Trial, Atacand, Blopress
Most Recently Shared on January 23, 2010 at 4:04 pm By:
China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug http://mnt.to/3wHH #clinicaltrials
Advertisement
